Edit |   |
---|---|
Antigenic Specificity | ALB & TNFA, Human (Ozoralizumab biosimilar) |
Clone | Ozoralizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | VH-VH'-VH |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human ALB & TNFA Recombinant Antibody. Ozoralizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases. Ozoralizumab was developed by Pfizer Inc, and now belongs to Ablynx NV. Ablynx has licensed the rights to the antibody in China to Eddingpharm. |
Immunogen | n/a |
Other Names | Anti-ALB & TNFA Recombinant Antibody, Research Grade Ozoralizumab, Anti-Human ALB & TNFA Recombinant Antibody, ATN-103, Antibody Drug Analogues, Monoclonal Antibody, YR1259, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1167985-17-2 |
Catalog # | YR1259 |
Price | please inquire |
Order / More Info | ALB & TNFA, Human (Ozoralizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |